Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement activation in patients with post-acute sequelae after SARS-CoV-2 infection.

Frontiers in immunology·2026
Same author

Implantation of a Continuous-Flow Left Ventricular Assist Device During Cardiopulmonary Bypass Is Associated with a Significant and Transient Acute Thromboinflammatory Response.

International journal of molecular sciences·2026
Same author

Distinct Proteomic and Transcriptomic Profiles in T-cells and Monocytes in Patients with Common Variable Immunodeficiency: an Exploratory Study.

Journal of clinical immunology·2026
Same author

Extracellular mitochondrial DNA activates complement and is associated with complement activation in patients with out-of-hospital cardiac arrest.

Scientific reports·2025
Same author

Inhibition of the complement component C5 and the Toll-like receptor molecule CD14 prevents systemic and local kidney inflammation in mice experiencing brain death.

Scientific reports·2025
Same author

Systemic inflammation is an important risk factor and predictor of graft loss and mortality one year after kidney transplantation.

Frontiers in immunology·2025
Same journal

m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma.

Molecular immunology·2026
Same journal

Overexpression of Hes1 inhibits cigarette smoke-induced mitochondrial apoptosis in AT2 cells by activating the Pgc-1α/Tfam signaling pathway.

Molecular immunology·2026
Same journal

Progesterone promotes favorable pregnancy outcomes in recurrent spontaneous, abortion by attenuating NK Cell overactivation and upregulating the cAMP/PKA/CREB signaling axis.

Molecular immunology·2026
Same journal

Oleanolic acid alleviates hepatic fibrosis by inhibiting liver macrophage recruitment and polarization.

Molecular immunology·2026
Same journal

Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury.

Molecular immunology·2026
Same journal

Endothelial-derived TWEAK drives granulosa cell apoptosis in PCOS via the Fn14-oxidative stress axis.

Molecular immunology·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Pathway-specific complement activity in pigs evaluated with a human functional complement assay.

Bodil Salvesen1, Tom E Mollnes

  • 1Institute of Immunology, University of Oslo and Rikshospitalet University Hospital, Oslo, Norway. bodil.salvesen@rr-research.no

Molecular Immunology
|March 31, 2009
PubMed
Summary
This summary is machine-generated.

The human complement Wielisa test can evaluate all three complement pathways in pig serum, aiding research in animal models. This functional complement assay is crucial for understanding innate immunity in pigs.

More Related Videos

Measuring the 50% Haemolytic Complement (CH50) Activity of Serum
08:26

Measuring the 50% Haemolytic Complement (CH50) Activity of Serum

Published on: March 29, 2010

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Experiment Videos

Last Updated: Jun 24, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Measuring the 50% Haemolytic Complement (CH50) Activity of Serum
08:26

Measuring the 50% Haemolytic Complement (CH50) Activity of Serum

Published on: March 29, 2010

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Area of Science:

  • Immunology
  • Innate Immunity

Background:

  • The complement system is vital for innate immunity, and its dysregulation can lead to severe diseases.
  • Functional complement testing is essential for research animals, particularly pigs, which are widely used in experimental studies.

Purpose of the Study:

  • To evaluate the applicability of the human complement functional test, Wielisa, for assessing all three complement activation pathways in pigs.

Main Methods:

  • The Wielisa assay, detecting complement activation via an anti-C9 antibody, was used with serially diluted normal pig serum.
  • Specificity was confirmed using purified human MBL and specific antibodies against C1q and factor D.
  • Functional complement activity was assessed in 103 adult and 38 newborn pig sera, and in vitro/in vivo with complement inhibitors.

Main Results:

  • The Wielisa assay demonstrated cross-reactivity with pig serum, enabling assessment of all complement pathways.
  • Pig serum required approximately 10-fold higher concentrations than human serum for comparable results.
  • Reduced lectin pathway activity was observed in a significant number of pigs, mirroring human findings.
  • The assay successfully monitored complement inhibition in pigs both in vitro and in vivo.

Conclusions:

  • The human Wielisa complement functional test is applicable for evaluating all complement pathways in pig serum.
  • This validated assay supports the use of pigs as a model for studying complement system function and related diseases.